Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind

June 21, 2011 4:36 am | by PositiveID | News | Comments

PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind

Physician Alignment Main Hurdle for ACOs

June 21, 2011 2:39 am | by Diagnostic Imaging | News | Comments

According to new survey results, physician alignment is the main problem when building accountable care organizations (ACOs).

Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma

June 20, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., June 20, 2011 /- Pharmaceutical Institute, the leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, announced today the completion of 2011 updates to its Therapeutic Area Essentials™...

Advertisement

Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

June 20, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers...

Panacea Global, Inc. Files Form 8-K to Announce Name Change; Trading Symbol Changes from MLXG to PANG

June 20, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

ONTARIO, Canada, June 20, 2011 /- Panacea Global Inc., ("the Company") (OTCQB: PANG), a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG....

Reportlinker Adds Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers

June 20, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers...

Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers

June 20, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers...

Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers

June 20, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers...

Advertisement

NYT: Double CT Scans Unnecessary, Cost Medicare $25 million a year

June 19, 2011 8:37 am | by Diagnostic Imaging | News | Comments

Hundreds of hospitals across the country needlessly exposed patients to radiation by giving patients doubled-up CT chest scans a front page article in Saturday's New York Times found.

Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products

June 17, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J., June 17, 2011 /PRNewswire-USNewswire/ -- Affineti Biologics has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its research in the development of therapeutic and diagnostic products based on new discoveries in oral...

Zen Holding Corp. Changes Name to Millennium HealthCare Inc.

June 17, 2011 8:31 am | by Bio-Medicine.Org | News | Comments

SYOSSET, N.Y., June 17, 2011 /- Zen Holding Corp. (Symbol: ZNHL) today announced that the Board of Directors has approved a name change to Millennium HealthCare Inc.  The Company will be filing with the regulatory authorities for a symbol change as well. About Zen Holding Corp. Zen...

NewCardio to Present at Wells Fargo Securities Healthcare Conference

June 17, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., June 17, 2011 /- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that Vincent Renz, Chief Executive Officer, is scheduled to present at the Wells Fargo Securities Healthcare Conference. The Conference is on June 22 and 23,...

Volcano Corporation Presentation at Wells Fargo Conference to be Webcast

June 17, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 17, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in...

Advertisement

Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa

June 16, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 16, 2011 /PRNewswire-Asia/ -- To expand our scope of services, Shenzhen Wuzhou Changlian International Trading Co. is going to establish a long-term business relationships with a city hospital in the Southeast of Africa soon, which will help local hospitals and...

Foundation Medicine appoints new COO Krenitsky

June 16, 2011 7:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Foundation Medicine Inc., a cancer diagnostics startup in Cambridge, has named former Enzo Clinical Labs president Kevin Krenitsky as chief operating officer of the company, where he will head the company's internal operations and plans for commercialization.

PositiveID Corporation Partners With MobiCare Technologies and CanCare Health Services to Launch iglucose mHealth Solution for Diabetes Management in Canada

June 15, 2011 5:33 am | by PositiveID | News | Comments

PositiveID Corporation Partners With MobiCare Technologies and CanCare Health Services to Launch iglucose mHealth Solution for Diabetes Management in Canada

Ethicon Endo-Surgery Introduces Innovative New Generator to Help Simplify Use of Advanced Energy Technology in the OR

June 15, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, June 15, 2011 /- In an effort to help simplify the OR, Ethicon Endo-Surgery, Inc. (EES) today announces U.S. FDA 510(k) clearance and the launch of the first ever Advanced Energy Generator made to power both ultrasonic and advanced bipolar technologies and designed for easy...

Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years

June 15, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 15, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years...

Scientists Image Beginning Stages of Ovarian Cancer Growth with Time Lapse Technique

June 14, 2011 10:34 am | by AACR | News | Comments

Tweet • New model of time-lapse microscopy provides better visualization of metastatic processes. • Knowledge could allow for therapeutic targeting to prevent metastasis. • NOTE TO PRODUCERS/EDITORS: Video footage available. PHILADELPHIA - Scientists at Harvard University have created a...

Incidence of Gastrointestinal Disorders in Patients With Parkinson's Disease Increased Over Time and Impacted Clinical and Health Economic Outcomes

June 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, June 14, 2011 /- A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to...

FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment

June 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a...

Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.

June 13, 2011 9:32 pm | by Bio-Medicine.Org | News | Comments

TOKYO, June 14, 2011 /- Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST® cTnI-II (cardiac Troponin I) diagnostic test, clearing the way for its sale in the...

Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16

June 13, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 13, 2011 /- Novelos Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present at the 5th  Lippert/Heilshorn Life...

2011 mHealth Summit: Call for Research Abstracts and Speakers Now Open

June 13, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., June 13, 2011 /- The Foundation for the National Institutes of Health, the mHealth Alliance, the Healthcare Information and Management Systems Society (HIMSS) and the National Institutes of Health (NIH) seek abstracts, presentations and speakers in the areas of research,...

PositiveID Corporation and Rogers Communications Partner to Improve Diabetes Management Through Innovative Mobile Technology

June 13, 2011 5:32 am | by PositiveID | News | Comments

PositiveID Corporation and Rogers Communications Partner to Improve Diabetes Management Through Innovative Mobile Technology

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading